홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Alendronic Acid → N-(N-(N-(4,4-bis(diallylphosphoryl)butyryl)glycyl)L-phenylalanyl)glycine

HRID 39266
노트
인쇄 미리보기

반응식

HRID 39266 반응식
[CH2:1](CN)[CH2:2][C:3]([P:9]([OH:12])(O)=O)([P:5](O)(O)=[O:6])O.CCN([CH:21]([CH3:23])[CH3:22])C(C)C.CN(C(ON1N=NC2C=C[CH:37]=[CH:38][C:33]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[NH2:48][CH2:49][C:50]([NH:52][C@H:53]([C:61]([NH:63][CH2:64][C:65]([OH:67])=[O:66])=[O:62])[CH2:54][C:55]1[CH:60]=[CH:59][CH:58]=[CH:57][CH:56]=1)=[O:51].CN([CH:71]=[O:72])C>C(OCC)(=O)C>[CH2:61]([P:5]([CH:3]([P:9]([CH2:23][CH:21]=[CH2:22])([CH2:33][CH:38]=[CH2:37])=[O:12])[CH2:2][CH2:1][C:71]([NH:48][CH2:49][C:50]([NH:52][C@H:53]([C:61]([NH:63][CH2:64][C:65]([OH:67])=[O:66])=[O:62])[CH2:54][C:55]1[CH:60]=[CH:59][CH:58]=[CH:57][CH:56]=1)=[O:51])=[O:72])([CH2:60][CH:55]=[CH2:56])=[O:6])[CH:53]=[CH2:54]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 5

HCID 2088Alendronic AcidHCID 6228DimethylformamideHCID 81531DiisopropylethylamineHCID 2733084Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 6992441Glycyl-phenylalanyl-glycine

생성물 1

HCID 87302179
N-(N-(N-(4,4-bis(diallylphosphoryl)butyryl)glycyl)L-phenylalanyl)glycine

시약·촉매·용매 1

HCID 8857Ethyl Acetate용매

반응 조건

온도
0 °C

실험 절차

To a solution of bisphosphonate 8 (400 mg, 0.98 mmol) in DMF (5 mL) at 0° C. was added DIEA (341 μL, 1.96 mmol) and HBTU (372 mg, 0.98 mmol). After stirring for 10 min at 0° C., the resulting activated ester solution was added to crude tripeptide 75 (0.98 mmol) and stirring was pursued for 2.5 h at 0° C. The reaction mixture was diluted with ethyl acetate, washed with H2O, 1N HCl solution, saturated NaHCO3 solution and saturated NaCl solution. The organic layer was dried over MgSO4, filtered and concentrated to dryness. The crude product was purified by silica gel chromatography on a Biotage™ flash chromatography system using a gradient of 0-10% methanol in ethyl acetate. Compound 76 was obtained as a colorless gum (652 mg, 92%). 1H NMR (400 MHz, CDCl3) δ 1.44 (s, 9H), 2.22-2.37 (m, 2H), 2.57 (t, J=6.4 Hz, 2H), 2.62 (tt, J=23.9, 7.0 Hz, 1H), 3.03-3.09 (m, 1H), 3.14-3.20 (m, 1H), 3.77-3.93 (m, 4H), 4.58-4.63 (m, 8H), 4.66-4.71 (m, 1H), 5.21-5.26 (m, 4H), 5.33-5.41 (m, 4H), 5.89-5.99 (m, 4H), 6.58-6.66 (m, 2H), 7.09 (d, J=8.2, 1H), 7.19-7.23 (m, 3H), 7.27-7.30 (m, 2H).

후처리

  1. stirringstirring
  2. waitwas pursued for 2.5 h at 0° C
  3. washwashed with H2O, 1N HCl solution, saturated NaHCO3 solution and saturated NaCl solution
  4. dry with materialThe organic layer was dried over MgSO4
  5. filtrationfiltered
  6. concentrationconcentrated to dryness
  7. customThe crude product was purified by silica gel chromatography on a Biotage™ flash chromatography system

출처 및 근거

ORD 기록
ord-ff1ade8889734ef28619030a99ed52be
출처 데이터셋
uspto-grants-2013_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08524691B2

반응 노트

불러오는 중…

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트